# Urine CXCL10 Chemokine Monitoring Post-renal Transplant

> **NCT03140514** · NA · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 241 (actual)

## Conditions studied

- Renal Transplant Rejection

## Interventions

- **DRUG:** Rejection treatment according to clinical standard-of-care

## Key facts

- **NCT ID:** NCT03140514
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-09-28
- **Primary completion:** 2022-07-15
- **Final completion:** 2022-07-15
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2022-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03140514

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03140514, "Urine CXCL10 Chemokine Monitoring Post-renal Transplant". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03140514. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*